P3bep clinical trial
WebNov 13, 2024 · P3BEP : Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours Male Only Status Recruiting Systemic Therapy Trial Phase Three 16-45 Age 16-45 Urinary System Cancers Trial Overview Read More WebAug 29, 2024 · Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with...
P3bep clinical trial
Did you know?
WebClinical Trials Patient Guide to Clinical Trials Phase 1 Program Main menu Supportive Care Cancer Rehabilitation Child Life Specialists Integrative Medicine Nutrition Oncoreproduction Clinic Pain Clinic Patient Navigators Physical Therapy Psychiatry and Psychology Sexual Health Sexuality Self Care Social Work Spiritual Health Support Groups WebFeb 20, 2024 · P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female …
WebAug 29, 2024 · Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric … WebPhase 3 Accelerated BEP Trial: A Randomised Phase 3 Trial of Accelerated versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-risk Metastatic Germ Cell …
WebJun 1, 2024 · P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs). Journal of Clinical Oncology Skip to main content Log In submission complete icon Submit envelope … WebOct 21, 2015 · Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours. BMC Cancer. 2024 Aug 29;18 (1):854. doi: 10.1186/s12885-018-4745-3.
WebFeb 26, 2024 · P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs). Journal of Clinical Oncology Journal of Clinical Oncology > List of Issues > Volume 36, Issue 6_suppl >
WebP3BEP ANZUP 1302 NSW VIC QLD SA TAS WA NZ UK USA Accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: a randomised phase III trial READ MORE > Testicular In Follow-up TIGER ANZUP 1604 NSW VIC QLD International pt wirralWebUK P3BEP Trial Trial description : A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell … pt wistara internasional maritimWebFeb 21, 2024 · Accelerating standard regimens by... P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and … hot crazy chart videoWebThis is an open-label, randomised, stratified 2-arm multicentre phase 3 clinical trial in patients with intermediate or poor risk categorised GCTs undertaken in two stages. The … pt wira global solusiWebFeb 19, 2024 · P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female … hot crazy graphWebClinical Trials in Genitourinary Cancers: KEYNOTE-641, P3BEP, and PIVOT-09 In the latest podcast from the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing potential new treatments for prostate cancer, germ cell tumors, and kidney cancer. Read More >> July 9, 2024 · Brielle Gregory, ASCO staff hot crawfishWebUK P3BEP Trial Research type Research Study Full title UK P3BEP - A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours IRAS ID 182633 Contact name Carrie Bayliss Contact email [email protected] Sponsor organisation pt with inr cpt